← All Century Therapeutics, INC filings

Century Therapeutics, INC Form 4 insider transactions

NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics CEO Granted Stock Options and Restricted Stock Units
Brent Pfeiffenberger, CEO of Century Therapeutics, received stock options and restricted stock units (RSUs) on March 7, 2024, according to a Form 4 filing with the SEC.
NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics SVP Douglas Carr Reports Stock and Option Awards
Douglas Carr, SVP of Finance & Operations at Century Therapeutics, reports the acquisition of 14,000 shares of common stock and options to purchase 81,000 shares.
NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics Executive Granted Stock Options and Restricted Stock Units
Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics, received stock options and restricted stock units (RSUs) according to a recent SEC Form 4 filing.
NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics' Officer Adrienne Farid Reports Stock and Option Grants
Adrienne Farid, Chief Operations Officer of Century Therapeutics, reports the acquisition of stock and option grants.
NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics' Officer Hyam Levitsky Reports Stock and Option Grants
Hyam Levitsky, President of R&D at Century Therapeutics, reports the acquisition of restricted stock units and stock options.
NASDAQ
IPSC
Century Therapeutics, INC
Form 4: Century Therapeutics' Chief Operations Officer Executes Stock Options and Sells Shares
Adrienne Farid, Chief Operations Officer of Century Therapeutics, exercised stock options and sold shares of common stock on March 6th and 7th, 2024, under a pre-arranged trading plan.